ING Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.5M | Sell |
799,842
-47,041
| -6% | -$1.25M | 0.14% | 126 |
|
|
2025
Q4 | $21.1M | Buy |
846,883
+74,769
| +10% | +$1.89M | 0.13% | 130 |
|
|
2025
Q3 | $19.7M | Sell |
772,114
-72,193
| -9% | -$1.78M | 0.11% | 127 |
|
|
2025
Q2 | $20.5M | Buy |
844,307
+87,011
| +11% | +$2.03M | 0.12% | 121 |
|
|
2025
Q1 | $19.2M | Sell |
757,296
-255,934
| -25% | -$6.7M | 0.13% | 113 |
|
|
2024
Q4 | $26.9M | Buy |
1,013,230
+331,403
| +49% | +$8.99M | 0.18% | 96 |
|
|
2024
Q3 | $19.7M | Sell |
681,827
-572,745
| -46% | -$16.7M | 0.11% | 136 |
|
|
2024
Q2 | $35.1M | Buy |
1,254,572
+460,286
| +58% | +$12.7M | 0.21% | 88 |
|
|
2024
Q1 | $22M | Sell |
794,286
-253,662
| -24% | -$7.04M | 0.15% | 121 |
|
|
2023
Q4 | $30.2M | Buy |
1,047,948
+59,719
| +6% | +$1.81M | 0.24% | 77 |
|
|
2023
Q3 | $32.8M | Sell |
988,229
-440,695
| -31% | -$15.6M | 0.29% | 75 |
|
|
2023
Q2 | $52.4M | Sell |
1,428,924
-685,302
| -32% | -$26.7M | 0.4% | 50 |
|
|
2023
Q1 | $86.3M | Buy |
2,114,226
+552,478
| +35% | +$23.9M | 0.84% | 25 |
|
|
2022
Q4 | $80M | Buy |
1,561,748
+647,900
| +71% | +$31.1M | 0.8% | 23 |
|
|
2022
Q3 | $40M | Sell |
913,848
-109,673
| -11% | -$5.33M | 0.67% | 36 |
|
|
2022
Q2 | $53.7M | Buy |
1,023,521
+101,119
| +11% | +$5.15M | 0.62% | 31 |
|
|
2022
Q1 | $47.8M | Buy |
922,402
+196,987
| +27% | +$10.2M | 0.48% | 40 |
|
|
2021
Q4 | $42.8M | Buy |
725,415
+256,273
| +55% | +$12.7M | 0.38% | 53 |
|
|
2021
Q3 | $20.2M | Sell |
469,142
-3,057
| -0.6% | -$135K | 0.26% | 68 |
|
|
2021
Q2 | $18.5M | Buy |
472,199
+96,055
| +26% | +$3.74M | 0.29% | 58 |
|
|
2021
Q1 | $13.6M | Buy |
376,144
+144
| +0% | +$5.11K | 0.28% | 61 |
|
|
2020
Q4 | $13.8M | Buy |
376,000
+139,530
| +59% | +$5.12M | 0.31% | 50 |
|
|
2020
Q3 | $8.23M | Buy |
236,470
+60,876
| +35% | +$2.13M | 0.34% | 43 |
|
|
2020
Q2 | $5.45M | Sell |
175,594
-158,106
| -47% | -$5.37M | 0.23% | 49 |
|
|
2020
Q1 | $10.3M | Sell |
333,700
-288,644
| -46% | -$9.84M | 0.44% | 38 |
|
|
2019
Q4 | $23.1M | Sell |
622,344
-131,202
| -17% | -$4.67M | 0.7% | 29 |
|
|
2019
Q3 | $25.7M | Sell |
753,546
-659,044
| -47% | -$24M | 0.65% | 28 |
|
|
2019
Q2 | $58.1M | Buy |
1,412,590
+990,594
| +235% | +$39.3M | 1.01% | 19 |
|
|
2019
Q1 | $17M | Sell |
421,996
-500,652
| -54% | -$20.1M | 0.37% | 55 |
|
|
2018
Q4 | $38.2M | Sell |
922,648
-255,678
| -22% | -$10.6M | 0.83% | 22 |
|
|
2018
Q3 | $49.3M | Sell |
1,178,326
-14,385
| -1% | -$554K | 0.85% | 25 |
|
|
2018
Q2 | $41.1M | Buy |
1,192,711
+747,014
| +168% | +$25.5M | 0.78% | 28 |
|
|
2018
Q1 | $15M | Sell |
445,697
-694,074
| -61% | -$23.9M | 0.27% | 62 |
|
|
2017
Q4 | $39.2M | Sell |
1,139,771
-1,033,310
| -48% | -$35.2M | 0.65% | 28 |
|
|
2017
Q3 | $73.6M | Buy |
2,173,081
+1,198,050
| +123% | +$38.5M | 1.42% | 12 |
|
|
2017
Q2 | $31.1M | Buy |
975,031
+541,908
| +125% | +$17.1M | 0.6% | 28 |
|
|
2017
Q1 | $14.1M | Sell |
433,123
-1,604,323
| -79% | -$50.6M | 0.25% | 71 |
|
|
2016
Q4 | $62.8M | Sell |
2,037,446
-299,588
| -13% | -$9.15M | 1.18% | 14 |
|
|
2016
Q3 | $73.9M | Sell |
2,337,034
-1,906,323
| -45% | -$63.7M | 0.89% | 21 |
|
|
2016
Q2 | $142M | Buy |
+4,243,357
| New | +$135M | 1.91% | 14 |
|
|
2016
Q1 | – | Sell |
-7,954,906
| Closed | -$244M | – | 647 |
|
|
2015
Q4 | $244M | Buy |
7,954,906
+76,328
| +1% | +$2.4M | 1.47% | 8 |
|
|
2015
Q3 | $235M | Sell |
7,878,578
-472,831
| -6% | -$15.2M | 1.62% | 10 |
|
|
2015
Q2 | $266M | Sell |
8,351,409
-18,207
| -0.2% | -$593K | 1.44% | 10 |
|
|
2015
Q1 | $276M | Sell |
8,369,616
-3,467,729
| -29% | -$110M | 1.39% | 10 |
|
|
2014
Q4 | $350M | Sell |
11,837,345
-4,956,628
| -30% | -$142M | 1.65% | 9 |
|
|
2014
Q3 | $471M | Sell |
16,793,973
-584,743
| -3% | -$16.4M | 2.74% | 3 |
|
|
2014
Q2 | $489M | Buy |
17,378,716
+3,634,046
| +26% | +$104M | 2.47% | 5 |
|
|
2014
Q1 | $419M | Buy |
13,744,670
+5,467,235
| +66% | +$163M | 2.21% | 4 |
|
|
2013
Q4 | $241M | Sell |
8,277,435
-113,532
| -1% | -$3.3M | 1.21% | 15 |
|
|
2013
Q3 | $229M | Sell |
8,390,967
-845,404
| -9% | -$23M | 1.15% | 14 |
|
|
2013
Q2 | $246M | Buy |
+9,236,371
| New | +$255M | 1.3% | 12 |
|
Other funds holding PFE
VCM
VPM
ING Group's PFE Position: Q1 2026 in Review
ING Group reduced its Pfizer (PFE) stake by 5.6% in Q1 2026, selling an estimated $1.25M and leaving 799,842 shares worth $22.5M. The position accounts for 0.14% of the portfolio, ranked #126.
ING Group first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $489M in Q2 2014. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- ING Group held 799,842 shares of Pfizer worth $22.5M as of Q1 2026.
- ING Group sold 47,041 Pfizer shares in Q1 2026, an estimated $1.25M.
- Pfizer made up 0.14% of ING Group's portfolio in Q1 2026, its #126 holding.
- ING Group first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- ING Group's Pfizer position peaked at $489M in Q2 2014.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on ING Group's 13F filing for Q1 2026, filed 11 May 2026.